bp of intron 1. Homologous recombination of the targeting vector into the NBS1 gene results in the introduction of autosomal recessive human disease whose clinical features include growth retardation, EcoRI and HincII sites adjacent to the neomycin resistance cassette ( Figure 1a ). These restriction sites were immunodeficiency, and increased susceptibility to lymphoid malignancies. Cells from NBS patients used for screening embryonic stem (ES) cells by southern blotting (Figure 1b) , and the genotypes of the neomycinexhibit ␥-irradiation sensitivity, S-phase checkpoint defects, and genomic instability. resistant transformants were subsequently confirmed by PCR analysis (Figure 1c resorbed embryos were found at e7.5-e10.5 (Table 1) .
report that in contrast to the viability of NBS patients, targeted inactivation of NBS1 in mice leads man NBS heterozygotes is high [3] , 100 NBS ϩ/Ϫ mice did not develop cancer spontaneously within 14 months, and to early embryonic lethality in utero and is associated with poorly developed embryonic and tumors were not apparent in NBS1 ϩ/Ϫ mice 7 months after treatment with 4 Gy ␥-irradiation (n ϭ 32). However, it extraembryonic tissues. Mutant blastocysts showed greatly diminished expansion of the inner remains possible that NBS1 ϩ/Ϫ mice may develop cancer at a more advanced age.
cell mass in culture, and this finding suggests that NBS1 mediates essential functions during proliferation in the absence of externally induced NBS1 ϩ/Ϫ mice were fertile, but when they were interbred, damage. Together, our results indicate that the homozygous mutants for the targeted NBS1 allele were complex phenotypes observed in NBS patients and not found among the 312 offspring analyzed from one of cell lines may not result from a complete inactivation the founder lines. These results indicate the embryonic of NBS1 but may instead result from hypomorphic lethality of the NBS1-deficient phenotype (Table 1) . To truncation mutations compatible with cell viability. determine the onset of lethality, we isolated embryos at various stages of gestation. At e7.5-e10.5 (where e ϭ embryonic day), no NBS1 Ϫ/Ϫ embryos were found among Addresses: *Experimental Immunology Branch, National Cancer the 66 analyzed. However, several decidua containing
Institute, National Institutes of Health, Bethesda, MD 20892, USA. † Mammalian Genetics Laboratory, National Cancer Institute, National resorbed embryos were found at e7.5-e10.5 (Table 1) .
Institutes of Health, Frederick, MD 20892, USA.
This suggests that the death of NBS1 Ϫ/Ϫ embryos occurred before e7.5.
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To further investigate the nature of the lethality, we ex- To test whether NBS1 Ϫ/Ϫ embryos survive until the blastocyst stage, we isolated preimplantation embryos at e3.5 of DNA spanning the NBS1 promoter, exon 1, and 700
Figure 1
Targeting of mouse NBS1 (a) Genomic structure of the wild-type NBS1 locus and targeting vector. A genomic clone was isolated from a mouse BAC library (Genome Systems) with a 700 bp BgII/PstI probe derived from the 5Ј end of mouse NBS1 cDNA. In the targeting vector and targeted allele, the neomycin selection cassette replaces the first NBS1 exon, including the translation initiation codon. Homologous recombination introduces EcoRI (E) and HincII (H) sites, which reduces the 11 kb wild-type EcoRI fragment and the 3.0 kb wild-type HincII fragment to 2 kb. Four successful targeting events were identified in 250 clones screened. and observed them on a daily basis as they grew in culture stage. When NBS1 ϩ/ϩ or NBS1 ϩ/Ϫ blastocysts were cultured in vitro, cells from the inner cell mass (ICM) proliffor 4 days (Figure 3a) . Out of 97 embryos genotyped on day 4, 12 were found to be NBS1 Ϫ/Ϫ (Figure 3b ; Table  erated rapidly and formed a colony on top of the trophoblast giant cells (Figure 3a , upper panels). In contrast, 1), and this finding indicates that at least some of the homozygous mutant embryos developed to the blastocyst abnormal ICM development became evident in NBS1 *The genetic background of the NBS1 ϩ/Ϫ mice is 129 ϫ C57BL/6, and genotyping failed for five embryos that lacked ICM at day 4 (e7.5). all the progeny and embryos are derived from one founder line. † PCR embryos after 2 days in culture, when the ICM appeared forms irradiation-induced foci that associate with DSBs until the damage is repaired [11] . Similarly, DSBs genersmaller than the controls. These ICM from NBS1 Ϫ/Ϫ embryos continued to diminish in size until the majority of ated during physiological V(D)J (variable, diversity, joining) recombination cause the redistribution of NBS1 to these cells died by day 4 in culture and left behind a monolayer of trophoblast giant cells (Figure 3a; lower sites of RAG-mediated V(D)J cleavage [12] . In NBS patient cells, which contain truncating or nonsense mutapanels). Nine out of twelve NBS1 Ϫ/Ϫ embryos lacked any detectable ICM by day 4, and the remaining three tions in NBS1, the formation of ionizing radiation-induced Mre11/Rad50 foci and the inhibition of DNA synthesis NBS1 Ϫ/Ϫ outgrowths were much smaller than those of the controls. Efforts to generate NBS1 Ϫ/Ϫ ES cell lines by in response to ␥-irradiation are abrogated [2, 13] . It has been speculated that these mutations in NBS result in either culturing NBS1 ϩ/Ϫ ES cells in high concentrations of G418 or by retargeting NBS1 ϩ/Ϫ ES cells by using an null alleles [1, 14] . However, the data presented here demonstrate that in contrast to the viability of NBS paindependently derived construct conferring hygromycin resistance also failed to generate any NBS1 Ϫ/Ϫ ES cells. tients, complete loss of NBS1 in mice leads to embryonic lethality associated with defective cellular proliferation. Thus, it appears that NBS1 is essential for growth of early embryonic cells.
Thus, we hypothesize that NBS patients may not carry null NBS1 alleles. Rather, they may express a truncated NBS1 protein that abrogates DSB recognition/signaling NBS1 plays a central role in detecting and signaling the functions but that still supports viability. Consistent with presence of DSBs, which may arise either as a result of this prediction, a 70 kDa protein, which may be an N external damage or during normal metabolic processes terminally truncated form of NBS1, has recently been A very similar scenario is observed in cells carrying mutations in MRE11. Hypomorphic alleles of human MRE11 have been discovered in an ataxia telangiectasia-like disorder, which, like NBS, is characterized by ␥-radiation sensitivity, defective cell cycle checkpoints, and increased genomic instability [15] . However, like NBS1 and RAD50 null mutations, homozygous disruption of MRE11 results in early embryonic lethality [16] . Recent studies in S. cerevisiae demonstrate that MRE11 is required for sister chromatid recombinational repair [17] . Likewise, MRE11 null chicken cells exhibit a reduced capacity for homologous recombination and undergo proliferative arrest associated with high levels of chromosome aberrations [18] . Additionally, MRE11 complexes have been found in association with blocked DNA replication forks [19] . Thus, it is possible that the failure to repair DSBs that arise spontaneously during DNA replication in MRE11
Ϫ/Ϫ embryos might lead to massive cell death during embryogenesis. This embryonic lethality appears not to be rescued by the loss of p53, as we have been unable to obtain live NBS1 Ϫ/Ϫ p53 Ϫ/Ϫ progeny (n ϭ 100) by crossing the NBS1 defect into the p53 Ϫ/Ϫ background. Similarly, the embryonic lethality phenotype caused by deficiencies in RAD51, BRCA1, and BRCA2 could not be rescued in a p53 null background [5, 20, 21] . These data raise the possibility that NBS1 may function in similar recombinational repair pathways that are required for maintaining genomic stability in the absence Histological sections of embryos grown in utero to e7.5. E6.5 and of exogenous damage. e7.5 decidua from NBS1 ϩ/Ϫ intercrosses were sectioned and stained with hematoxylin and eosin. A midsagital section is shown for normal and presumed mutant embryos. Abbreviations are as follows: ee,
Figure 3
Defective growth of NBS1 Ϫ/Ϫ blastocysts in vitro. (a) E3.5 blastocysts l lysis buffer (100 mM KCl, 10 mM Tris HCl, 2.5 mM MgCl 2 , 0.45% were isolated from NBS1 ϩ/Ϫ intercrosses and cultured in 96 well Tween 20, 0.45% NP40, and 1 mg/ml proteinase K) for 4-5 hr at plates. Pictures were taken on a daily basis with a phase contrast 55ЊC. DNA samples (3-5 l) were used for genotyping. In the first microscope (Zeiss Axiovert 100) prior to genotyping by PCR. The round of PCR, a common primer, C1400 (5Ј-GGCTAAGA upper panel shows growth of NBS1 ϩ/Ϫ blastocysts, and the lower TGTATTGCTCCG-3Ј), a wild-type specific primer, W210 (5Ј-panel is an example of NBS1 Ϫ/Ϫ blastocyst outgrowth. Inner cell GGATCTGGGAAGCTAAAGTATG-3Ј), and a mutant primer, 3PNT mass (ICM) and trophoblast giant cells (TGC) are indicated. The scale (5Ј-TAAAGCGCATG CTCCAGACT-3Ј) were used. For the second bar represents 100 m. (b) Examples of PCR genotyping of blastocysts round of PCR, primers Com133, W123, and Mut2 (indicated in after 4 days in vitro culture. A nested PCR strategy was used. DNA Figure 1 ) were used to amplify both wild-type and mutant fragments. preparation was by the incubation of individual blastocysts with 20 5. Lim DS, Hasty P: A mutation in mouse rad51 results in an early
